Difference between revisions of "Coagulopathy (main)"
(→Source) |
(→Differential Diagnosis) |
||
| Line 1: | Line 1: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| − | + | {{Increased bleeding DDX}} | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
===Increased Clotting=== | ===Increased Clotting=== | ||
Revision as of 12:35, 10 June 2015
Contents
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Managment
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Reversing known medications